v3 Template
P

PharmaCyte Biotech, Inc.

Biotechnology ~105 employees
Founded
--
Employees (Est.)
~105
7 leaders known
Total Funding
$14.0M
Funding Rounds
2
Last Funding
2025-08-20

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company focused on developing innovative therapies and solutions in the biotech sector.

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Financing
T: -
FT: Financing
A: 7000000
MR: -
FA: $7 million
FAN: 7000000
D: 2025-08-20
FD: 2025-08-20
-
2 RT: Private Placement of Series C Convertible Preferred Stock
T: -
FT: Private Placement of Series C Convertible Preferred Stock
A: 7000000
MR: -
FA: $7.0 million
FAN: 7000000
D: 2025-08-18
FD: 2025-08-18
1 investors
Financing Latest
2025-08-20
$7.0M
Private Placement of Series C Convertible Preferred Stock 2025-08-18
$7.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Joshua N. Silverman

Interim Chief Executive Officer, President, and Director

M

Michael M. Abecassis

Director

J

Jonathan L. Schechter

Director

W

Wayne R. Walker

Director

R

Robert Weinstein

Director

C

Carlos A. Trujillo

Chief Financial Officer

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

PharmaCyte Biotech, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~105 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro